Emergent BioSolutions to Participate in June and July 2013 Investor
Wells Fargo Healthcare Conference 2013
ROCKVILLE, Md. -- June 6, 2013
Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the
company’s senior management team will participate in the following investor
conferences during June and July 2013:
*Wells Fargo Securities Research & Economics 2013 Healthcare Conference
June 18-19, 2013
*Janney Capital Markets Boston Healthcare 1X1 Corporate Access Day
June 27, 2013
*8^th Annual JMP Securities Healthcare Conference
New York, NY
July 9-10, 2013
For the Janney Capital Markets conference, the company will only be
participating in one-on-one meetings. The format of the conference does not
include formal presentations.
For the Wells Fargo and JMP conferences, the company will be webcasting its
formal presentations which will encompass a corporate overview and may include
a discussion of the company's recent business developments as well as its
current financial results and financial guidance for the current year and
latest quarterly period. The webcasts will be available both live and by
replay, accessible from the Emergent website www.emergentbiosolutions.com
About Emergent BioSolutions Inc.
Emergent BioSolutions is a specialty pharmaceutical company seeking to protect
and enhance life by offering specialized products to healthcare providers and
governments to address medical needs and emerging health threats. Additional
information about us may be found at www.emergentbiosolutions.com.
Follow us on Twitter: @emergentbiosolu.
Emergent BioSolutions Inc.
Robert G. Burrows
Vice President, Investor Relations
Vice President, Corporate Communications
Press spacebar to pause and continue. Press esc to stop.